全文获取类型
收费全文 | 226843篇 |
免费 | 20041篇 |
国内免费 | 5030篇 |
专业分类
耳鼻咽喉 | 3274篇 |
儿科学 | 4244篇 |
妇产科学 | 3697篇 |
基础医学 | 17288篇 |
口腔科学 | 7295篇 |
临床医学 | 20410篇 |
内科学 | 21857篇 |
皮肤病学 | 2664篇 |
神经病学 | 12043篇 |
特种医学 | 5834篇 |
外国民族医学 | 12篇 |
外科学 | 20839篇 |
综合类 | 35862篇 |
现状与发展 | 9篇 |
一般理论 | 27篇 |
预防医学 | 28393篇 |
眼科学 | 2117篇 |
药学 | 28315篇 |
339篇 | |
中国医学 | 27843篇 |
肿瘤学 | 9552篇 |
出版年
2024年 | 618篇 |
2023年 | 4267篇 |
2022年 | 6759篇 |
2021年 | 10896篇 |
2020年 | 10608篇 |
2019年 | 12009篇 |
2018年 | 10720篇 |
2017年 | 9420篇 |
2016年 | 8411篇 |
2015年 | 7865篇 |
2014年 | 15621篇 |
2013年 | 16519篇 |
2012年 | 13994篇 |
2011年 | 14904篇 |
2010年 | 11978篇 |
2009年 | 10277篇 |
2008年 | 9512篇 |
2007年 | 9645篇 |
2006年 | 8195篇 |
2005年 | 6971篇 |
2004年 | 5779篇 |
2003年 | 5194篇 |
2002年 | 3999篇 |
2001年 | 3384篇 |
2000年 | 2961篇 |
1999年 | 2415篇 |
1998年 | 1958篇 |
1997年 | 1786篇 |
1996年 | 1465篇 |
1995年 | 1405篇 |
1994年 | 1254篇 |
1993年 | 1150篇 |
1992年 | 1068篇 |
1991年 | 947篇 |
1990年 | 838篇 |
1989年 | 788篇 |
1988年 | 752篇 |
1987年 | 639篇 |
1986年 | 608篇 |
1985年 | 1898篇 |
1984年 | 2163篇 |
1983年 | 1357篇 |
1982年 | 1794篇 |
1981年 | 1239篇 |
1980年 | 1078篇 |
1979年 | 955篇 |
1978年 | 796篇 |
1977年 | 606篇 |
1976年 | 739篇 |
1975年 | 519篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
71.
72.
73.
当代社会,老年人口比例呈现不断上升的趋势,老龄化问题日益严峻。因此,如何有效地延缓衰老不仅成为了世界医学研究的热点,也成为了全球亟待解决的问题。中医药在延缓衰老方面经验丰富,而滋阴药在此类研究中效果显著。本文通过整理滋阴药抗衰老作用机制的若干文献,对滋阴复方六味地黄丸、二至丸、左归丸及其他滋阴中药延缓衰老的机制研究进展进行综述。 相似文献
74.
Cristiano Colalto 《Drug development research》2020,81(8):950-968
COVID-19 is a novel coronavirus disease with a higher incidence of bilateral pneumonia and pleural effusion. The high pulmonary tropism and contagiousness of the virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have stimulated new approaches to combat its widespread diffusion. In developing new pharmacological strategies, the chemical characteristic of volatility can add therapeutic value to the hypothetical drug candidate. Volatile molecules are characterized by a high vapor pressure and are consequently easily exhaled by the lungs after ingestion. This feature could be exploited from a pharmacological point of view, reaching the site of action in an uncommon way but allowing for drug delivery. In this way, a hypothetical molecule for COVID-19 should have a balance between its lung exhalation characteristics and both antiviral and anti-inflammatory pharmacological action. Here, the feasibility, advantages, and disadvantages of a therapy based on oral administration of possible volatile drugs for COVID-19 will be discussed. Both aerosolized antiviral therapy and oral intake of volatile molecules are briefly reviewed, and an evaluation of 1,8-cineole is provided in view of a possible clinical use and also for asymptomatic COVID-19. 相似文献
75.
76.
近10年来,甲状腺外科快速发展。随着甲状腺外科相关指南、专家共识的不断修订与完善,在专业团体的引导下,中国甲状腺外科在术前诊断、手术方式、治疗方法创新等方面实现了可喜发展,病人5年生存率明显提高。甲状腺疾病诊治技术快速革新、外科术式的发展与统一、多学科诊疗模式发展与应用、术后规范化管理助力疗效提高、重视特殊情况下的甲状腺癌及髓样癌诊治以及质量控制体系的建立与完善等综合发展提升了甲状腺癌诊疗的安全性、精准性,有效的改善了病人生活质量、延长生存时间,为建设健康中国贡献力量。 相似文献
77.
78.
《Archives of Cardiovascular Diseases》2022,115(10):505-513
Central illustration: cumulative major adverse cardiac events (MACE) and bioresorbable vascular scaffold (BVS) thrombosis rates after 1, 2, 3, 4 and 5 years. 相似文献
79.
Yesim Aydinok 《ISBT科学丛刊》2020,15(1):102-109
Lifetime red cell concentrate (RCC) transfusions still account for significant iron overload‐related morbidity and mortality despite chelation therapy in thalassaemia. The cumulative risk of transfusion‐transmitted infections is substantial for thalassaemia patients. Pathogen reduction technologies for RCC may imply a proactive approach against new/re‐emerging pathogens and may be an ultimate safeguard for transfusion safety in the developing countries. Red cell alloimmunization may become a significant clinical challenge in thalassaemia. The availability of high‐throughput molecular blood group antigen typing in the donors may allow perfect match transfusion, beyond ABO‐D and CEK antigen‐matched transfusions. Allogeneic stem cell transplantation (A‐SCT) is the only available curative therapy in thalassaemia, but carries a substantial risk of serious adverse events and mortality. Gene addition therapy for correction of the α‐globin chain imbalance overcomes the problems of donor availability and immunological complications of A‐SCT. Gene editing by either gene disruption or correction emerged as a potential alternative to gene addition therapy in beta‐thalassaemia. A new era of novel therapeutics targeting α/β imbalance, ineffective erythropoiesis or iron dysregulation is unfolding in thalassaemia management, and a number of those now have agents in preclinical and clinical development. Hydroxyurea (HU) may improve globin chain imbalance and be beneficial for reducing or omitting transfusion requirement. Ruxolitinib has allowed steady decrease in spleen volume that may serve for avoiding splenectomy in beta‐thalassaemia. Luspatercept may restore normal erythroid differentiation and improve anaemia. Hepcidin mimetics or TMPRSS6 inhibitors may modulate ineffective erythropoiesis by iron restriction and improve anaemia and organ iron loading. 相似文献
80.
《European journal of medical genetics》2020,63(9):103981
Congenital diarrhea and enteropathies (CODEs) are a group of monogenic disorders that often present with severe diarrhea in the first weeks of life. Enteric anendocrinosis (EA), an extremely rare cause of CODE, is characterized by a marked reduction of intestinal enteroendocrine cells (EC). EA is associated with recessively inherited variants in Neurogenin-3 (NEUROG3) gene. Here we investigate a case of a male infant who presented with mysterious severe malabsorptive diarrhea since birth. Thorough clinical assessments and laboratory tests were successful to exclude the majority of differential diagnosis categories. However, the patient's diagnosis was not established until the genetic test using whole-exome sequencing (WES) was performed. We identified a novel homozygous missense disease-causing variant (DCV) in NEUROG3 (c.413C>G, p.Thr138Arg). Moreover, molecular dynamic simulation analysis showed that (p.Thr138Arg) led to a global change of the NEUROG3 orientation affecting its DNA binding capacity. To the best of our knowledge, this is the first time to apply WES to reach a differential diagnosis of patients with CODEs. Our study not only expands our knowledge about NEUROG3 variants and their clinical consequences but also proves that WES is a very effective tool for the diagnosis of CODEs. This might be of value in early diagnosis of diseases and prenatal CODEs detection. 相似文献